Scientists at the Wellcome Sanger Institute have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought. These results create safety implications for gene therapies using CRISPR/Cas9 in the future as the unexpected damage could lead to dangerous changes in some cells.
Reported today (16 July 2018) in the journal Nature Biotechnology, the study also revealed that standard tests for detecting DNA changes miss finding this genetic damage, and that caution and specific testing will be required for any potential gene therapies.
CRISPR/Cas9 is one of the newest genome editing tools. It can alter sections of DNA in cells by cutting at specific points and introducing changes at that location. Already extensively used in scientific research, CRISPR/Cas9 has also been seen as a promising way to create potential genome editing treatments for diseases such as HIV, cancer or sickle cell disease. Such therapeutics could inactivate a disease-causing gene, or correct a genetic mutation. However, any potential treatments would have to prove that they were safe.
Previous research had not shown many unforeseen mutations from CRISPR/Cas9 in the DNA at the genome editing target site. To investigate this further the researchers carried out a full systematic study in both mouse and human cells and discovered that CRISPR/Cas9 frequently caused extensive mutations, but at a greater distance from the target site.
The researchers found many of the cells had large genetic rearrangements such as DNA deletions and insertions. These could lead to important genes being switched on or off, which could have major implications for CRISPR/Cas9 use in therapies. In addition, some of these changes were too far away from the target site to be seen with standard genotyping methods.
“This is the first systematic assessment of unexpected events resulting from CRISPR/Cas9 editing in therapeutically relevant cells, and we found that changes in the DNA have been seriously underestimated before now. It is important that anyone thinking of using this technology for gene therapy proceeds with caution, and looks very carefully to check for possible harmful effects.”
Professor Allan Bradley, corresponding author on the study from the Wellcome Sanger Institute
“My initial experiment used CRISPR/Cas9 as a tool to study gene activity, however it became clear that something unexpected was happening. Once we realised the extent of the genetic rearrangements we studied it systematically, looking at different genes and different therapeutically relevant cell lines, and showed that the CRISPR/Cas9 effects held true.”
Michael Kosicki, the first author from the Wellcome Sanger Institute
The work has implications for how CRISPR/Cas9 is used therapeutically and is likely to re-spark researchers’ interest in finding alternatives to the standard CRISPR/Cas9 method for gene editing.
“This study is the first to assess the repertoire of genomic damage arising at a CRISPR/Cas9 cleavage site. While it is not known if genomic sites in other cell lines will be affected in the same way, this study shows that further research and specific testing is needed before CRISPR/Cas9 is used clinically.”
Professor Maria Jasin, an independent researcher from Memorial Slone Kettering Cancer Centre, New York, who was not involved in the study
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- Chinese scientists develop gene therapy that could delay ageingon January 19, 2021 at 5:00 pm
A new gene therapy has been shown to reverse some of the effects of ageing in mice and extend their lifespans by up to a quarter. Chinese researchers used CRISPR-Cas9, a powerful gene-editing tool, to ...
- Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switchon January 19, 2021 at 2:45 pm
Cas9 systems avoid causing autoimmunity in bacteria when they complex with a natural single-guide RNA that is a long-form tracrRNA that targets a Cas9 promoter.
- Gene-cutting system may play second role as a genetic dimmer switchon January 19, 2021 at 7:54 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9 -- as a ...
- CRISPR technology shown to dial down gene activity in bacteriaon January 19, 2021 at 7:31 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9—as a genetic ...
- Gene-editing 'scissor' tool may also be a 'dimmer switch'on January 19, 2021 at 6:03 am
In a series of experiments with laboratory-cultured bacteria, Johns Hopkins scientists have found evidence that there is a second role for the widely used gene-cutting system CRISPR-Cas9 -- as a genet ...
- TOP delivery of CRISPR-Cas9 machinery to primary T cellson January 18, 2021 at 10:44 am
The last 10 years have witnessed the remarkable advancement of CRISPR-Cas9 technology from discovery to early development to its clinical application to treat various diseases. However, CRISPR-Cas9 ...
- 7 CRISPR Stocks for the Future of Medicineon January 15, 2021 at 3:12 pm
Doudna and Charpentier noted a naturally occurring genome editing system in bacteria, wherein bacteria capture snippets of DNA from invading viruses and create new DNA segments called CRISPR arrays ...
- One step closer to CRISPR-Cas9 cancer therapieson January 15, 2021 at 5:16 am
Cas9 cancer therapies. Once CRISPR-Cas9 genome editing technology became available, scientists worldwide began using it to learn more ab ...
- Detecting CRISPR-Cas9 Gene Doping in Athleteson January 13, 2021 at 11:28 am
Cas9 could allow persons to manipulate babies by changing their eye color or hair color, for example. Now, German researchers have extrapolated that situation further—what if athletes are tempted to ...
via Bing News